US Patent 9758565 Methods of treatment using CTLA4 mutant molecules
Patent 9758565 was granted and assigned to Bristol-Myers Squibb on September, 2017 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
May 29, 2014
Date of Patent
September 12, 2017
Patent Applicant
Patent Application Number
14289715
Patent Citations Received
Patent Inventor Names
Joseph Naemura
0
Robert James Peach
0
Peter S. Linsley
0
Jurgen Bajorath
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9758565 Methods of treatment using CTLA4 mutant molecules
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
